The Healthcare segment focuses on the development, manufacturing, and marketing of noninvasive patient monitoring technologies and hospital automation solutions. This includes Masimo SET pulse oximetry, rainbow SET Pulse CO-Oximetry, SedLine brain function monitoring, capnography and gas monitoring, O3 regional oximetry, and hemodynamic monitoring solutions. Research and development efforts are focused on improving the accuracy and reliability of patient monitoring, expanding the range of measurable parameters, and integrating monitoring solutions into hospital automation platforms like Patient SafetyNet. The segment aims to improve patient outcomes, reduce the cost of care, and enhance clinical workflows. Market positioning is strong due to the company's innovative technologies and strong partnerships. Future opportunities include expansion into new clinical applications and geographic markets. Regulatory compliance and clinical validation are critical aspects of this segment, with products requiring FDA approval and other certifications.

This segment encompasses Masimo's expansion into the consumer audio market, primarily through the acquisition of Sound United. It involves the design, manufacturing, and distribution of high-quality audio products. Research and development activities focus on enhancing audio performance, integrating advanced technologies, and expanding product offerings. The segment aims to provide consumers with premium audio experiences. Market positioning is competitive, with a focus on innovation and brand recognition. Future opportunities include expanding the product portfolio, entering new markets, and leveraging Masimo's technological expertise in audio products. Regulatory compliance and quality assurance are essential for ensuring product safety and performance. Partnerships with retailers and distributors are crucial for market access and sales.